Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Henryschein Dental Company (NQ:HSIC)

62.68 -0.57 (-0.90%)
Streaming Delayed Price Updated: 12:47 PM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Henryschein Dental Company

< Previous 1 2 3 4 5 6 7 Next >
1 Value Stock to Target This Week and 2 We Ignore
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few... 
Via StockStory
3 Reasons to Avoid HSIC and 1 Stock to Buy Instead
Henry Schein currently trades at $64.88 per share and has shown little upside over the past six months, posting a middling return of 3.5%. The stock also fell short of the S&P 500’s 34.7% gain during... 
Via StockStory
Topics Stocks
Which S&P500 stocks are gapping on Monday?
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Monday to uncover the stocks that are gapping in the S&P500 index. 
Via Chartmill
1 Profitable Stock for Long-Term Investors and 2 We Brush Off
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
Topics Economy
Earnings Scheduled For August 5, 2025
 
Via Benzinga
Peering Into Henry Schein Inc's Recent Short Interest
 
Via Benzinga
2 Safe-and-Steady Stocks to Target This Week and 1 Facing Headwinds
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
Why Henry Schein (HSIC) Shares Are Trading Lower Today
Shares of dental and medical products company Henry Schein (NASDAQ:HSIC) fell 2.7% in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical... 
Via StockStory
Topics World Trade
What Analysts Are Saying About Henry Schein Stock
 
Via Benzinga
Henry Schein Sees Steady Smile As Dental Market Growth Holds: Analyst
Henry Schein sees steady dental market trends, with Piper Sandler expecting stronger equipment growth in the second half of 2025. 
Via Benzinga
Dental Equipment & Technology Stocks Q2 Recap: Benchmarking Henry Schein (NASDAQ:HSIC)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at dental equipment & technology stocks,... 
Via StockStory
1 S&P 500 Stock for Long-Term Investors and 2 We Question
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural... 
Via StockStory
Topics Stocks
What Analysts Are Saying About Henry Schein Stock
 
Via Benzinga
This Henry Schein Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
 
Via Benzinga
HSIC Q2 Deep Dive: Margin Pressures Persist Despite Solid Revenue, New Initiatives Announced
Dental and medical products company Henry Schein (NASDAQ:HSIC) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 3.3% year on year to $3.24 billion. Its non-GAAP profit of $1.10 per... 
Via StockStory
Deep Dive Into Henry Schein Stock: Analyst Perspectives (6 Ratings)
 
Via Benzinga
Top S&P500 movers in Tuesday's session
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Tuesday. 
Via Chartmill
Why Henry Schein (HSIC) Shares Are Falling Today
Shares of dental and medical products company Henry Schein (NASDAQ:HSIC) fell 9.7% in the afternoon session after the company reported second-quarter earnings that missed profit expectations and showed... 
Via StockStory
Topics Artificial Intelligence Stocks World Trade
Which S&P500 stocks are moving on Tuesday?
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Tuesday as we examine the latest happenings in today's session. 
Via Chartmill
Henry Schein (HSIC) Q2 EPS Drops 11%
Via The Motley Fool
What's going on in today's session: S&P500 gap up and gap down stocks
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Tuesday to uncover the stocks that are gapping in the S&P500 index. 
Via Chartmill
Henry Schein's 2025 Outlook Hinges On Strong Second-Half Execution
Henry Schein Inc. stock down on Q2 earnings, misses EPS but beats sales. Total net sales up 3.3%, $23M in restructuring costs. FY2025 guidance affirmed. 
Via Benzinga
Topics Earnings
Discover the top S&P500 movers in Tuesday's pre-market session.
Stay updated with the S&P500 stocks that are on the move in today's pre-market session. 
Via Chartmill
Henry Schein’s (NASDAQ:HSIC) Q2 Earnings Results: Revenue In Line With Expectations
Dental and medical products company Henry Schein (NASDAQ:HSIC) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 3.3% year on year to $3.24 billion. Its non-GAAP profit of $1.10 per... 
Via StockStory
Henry Schein (HSIC) Reports Earnings Tomorrow: What To Expect
Dental and medical products company Henry Schein (NASDAQ:HSIC) will be reporting results this Tuesday morning. Here’s what investors should know. 
Via StockStory
Topics Economy World Trade
Assessing Henry Schein: Insights From 6 Financial Analysts
 
Via Benzinga
Nasdaq To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Friday
 
Via Benzinga
This Norfolk Southern Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
 
Via Benzinga
Acadia Healthcare, Henry Schein, The Pennant Group, Ziff Davis, and Atlassian Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after a new trade agreement between the United States and Japan spurred a broad market rally. The positive sentiment swept across markets after it was... 
Via StockStory
Topics Lawsuit Stocks World Trade
ZimVie Doubles — And Then Some — On Its Second Takeover Deal
The Zimmer Biomet spinoff is looking to head for private waters under the fund Archimed. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.